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The variability between respiratory syncytial virus (RSV) strains is one of the features of RSV 
infections that might contribute to the ability of the virus to infect people repeatedly and cause 
yearly outbreaks. To study themolecular epidemiology of RSV, more than 1,400 RSV isolates 
from human nasopharyngeal aspirates or nasal or throat swabs from patients with respiratory 
illness were identified and differentiated by TaqMan reverse transcription-PCR into groups A 
and B. RSV group A was dominant in seven out of nine epidemic seasons. 
Phylogenetic analysis revealed that RSV group A genotypes GA2 and GA5 circulated from 1998 
to 2007. Genotype GA7 was present in only two seasons (1999 to 2000 and 2002 to 2003). 
Comparison of the synonymous mutation/nonsynonymous mutation ratios showed greater 
evidence for selection pressure for genotype GA2 (1.18) than for GA5 (4.34). Partial protein 
sequences were predicted to encode G proteins of 298 amino acids in length and in a few 
cases of G proteins of 297 amino acids in length. Amino acid analysis also revealed 
genotype-specific amino acid substitutions: two substitutions for genotype GA2, seven for 
GA5, and three for GA7. Two to four putative, genotype-specific N-linked glycosylation sites 
were determined. Predicted Oglycosylation sites included 22 to 34 residues. This study 
provides for the first time data on the circulation pattern of RSV group A genotypes and their 
molecular characterization in Germany during nine consecutive epidemic seasons. 
 
 
Worldwide, the respiratory syncytial virus (RSV) is the major pathogen of lower respiratory tract 
infections in infants and young children in both developing and developed countries (46). By the age of 
2 years, virtually all children have been infected at least once with RSV (16). Nevertheless, 
reinfections are very common throughout life. In older children and adults, they are usually associated 
with milder disease, indicating that RSV infections induce only partial immunity (19).  
 
RSV strains are separated into two major groups based on antigenic and genetic variability. The main 
differences between RSV groups A and B were found in the attachment glycoprotein G (1, 6, 30). 
Variability in this protein is greater than that in the other proteins, both between and within the major 
antigenic groups of RSV. The G protein is a type II glycoprotein of 289 to 299 amino acids in length, 
consisting of two hypervariable regions in the extracellular domain. Diversity occurs mainly in the G 
ectodomain which has only 44% amino acid identity between the two groups compared with 83% for 
the transmembrane and cytoplasmic domains (21). The G protein is heavily glycosylated with N-linked 
and O-linked sugars (60). Mainly, the ectodomain of the G protein has a high content of serine and 
threonine residues which are potential acceptor sites for O-linked sugars. However, the amino acid 
sequence positions of potential N-linked and O-linked glycosylation sites are poorly conserved, 
although the general locations of the latter are similar (21). Amino acid variations of the protein exist in 
both groups, but variations are more pronounced in RSV group A (39, 51). Most molecular analyses 
include the second variable region of the G protein, coding for the Cterminal end of the protein. Eight 
RSV group A genotypes, named GA1 to GA7 and South Africa A1 (SAA1) have been described so far 
(38, 39, 51). Genotype analysis of RSV group A is limited to particular countries worldwide. In Europe, 
for instance, genotypic RSV group A data are provided only from Belgium and Sweden (40, 62, 63).  
 
Variability between RSV strains is one of the features of RSV infections that might contribute to the 
ability of the virus to infect people repeatedly and cause yearly outbreaks (38). RSV has a clear 
seasonality. In temperate climates, outbreaks occur yearly in the late fall, winter, or spring but not in 
the summer (22, 29, 61). Both RSV groups can be present in the same community, and their relative 
proportions may differ between epidemics (2, 4, 13, 20), although group A viruses tend to predominate 
(8). 
 
There is limited information regarding the molecular epidemiology of RSV in Germany. For the first 
time, we describe both the genetic variability of RSV group A viruses and the circulation pattern of 





Materials and Methods 
 
Clinical samples.  
Human nasopharyngeal aspirates or nasal or throat swabs from patients with respiratory illness were 
sent to the Robert Koch-Institut from two hospitals and about 150 medical practices between October 
1998 and September 2007. The medical practices were located all over Germany. Specimens 
collected at the time of admission were forwarded undiluted. Immediately upon arrival, swabs were 
resuspended in 5 ml of sterile minimal essential medium with HEPES (Gibco BRL, Eggenstein, 
Germany) and 100 U/ml penicillin-streptomycin (GIBCO), aliquoted, and stored at -70°C. 
Nasopharyngeal aspirates were adjusted to a volume of 3 ml with the minimal essential medium 
described above.  
During the period of examination, a total of 6,115 samples were collected and tested for RSV.  
These included samples from 713 (12%) infants less than 3 months old, 497 samples (8%) of those 
aged 3 to 6 months, 640 samples (10%) of those aged 7 to 12 months, and 1,719 samples (28%) of 
children 1 to 3 years old; 2,328 (38%) samples were from patients more than 3 years old, and 218 
samples (4%) were from individuals of unknown age. 
 
 
RNA preparation and cDNA synthesis.  
RNA extraction was performed from 400 μl of the diluted specimens using RTP DNA/RNA virus minikit 
(Invitek, Berlin, Germany) according to the manufacturer’s instructions. cDNA was synthesized with 25 
μl of RNA in a mixture containing a 500 nM concentration of random hexamer primers, a 200 μM 
concentration of each deoxynucleoside triphosphate (Invitrogen, Karlsruhe, Germany), 2.5 mM 
dithiothreitol (Invitrogen), 40 U RNasin (Promega, Madison, WI), 200 U Moloney murine leukemia virus 
reverse transcriptase (Invitrogen), and first-strand buffer (Invitrogen), containing 250 mM Tris-HCl (pH 
8.3), 375 mM KCl, and 15 mM MgCl2, in a final volume of 40 μl. The synthesis of cDNA was carried 
out for 5 min at 42°C, followed by 35 min at 37°C, and finally for 5 min at 94°C. 
 
 
Real-time PCR for RSV detection.  
For detection of RSV, cDNA was first analyzed by a generic RSV TaqMan PCR targeting the RSV N-
protein gene. PCR was performed in a 25-μl reaction mixture using 5 μl of cDNA product, 250 nM of 
each of the primer pairs RSV-N15-F and RSV-N184-R, 200 nM of the RSV-N106-S probe (Table 1), 1 
μM 6-carboxy-X-rhodamine, 100 μM deoxynucleoside triphosphates, 5 mM MgCl2 (Invitrogen), 0.5 U 
of Platinum Taq DNA polymerase (Invitrogen), and PCR buffer (200 mM Tris-HCl [pH 8.4], 500 mM 
KCl). Amplification was carried out at 95°C for 5 min, followed by 45 cycles of PCR, with 1 cycle 
consisting of 15 s at 95°C and 30 s at 60°C, and a final extension step of 15 min at 72°C.  
Following this, RSV-positive samples were differentiated into RSV group A and B by group-specific 
real-time PCRs targeting the large glycoprotein gene (G gene). Since the focus is on RSV group A, 
only these conditions are described here. cDNA product (5 μl) was amplified in a 25-μl reaction 
mixture and the same amplification conditions as mentioned above. Specific RSV group A 
amplification was carried out using the primer pairs RSVA-G409-F and RSVAG586- R as well as the 
RSVA-G556-S probe (Table 1).  
All reactions were carried out using an ABI PRISM 7700 sequence detection system and 7900HT 
sequence detection system (Applied Biosystems, Darmstadt, Germany). 
 
 
Analysis of RSV epidemic seasons.  
For each season, RSV-positive samples were estimated per calendar week. In order to determine the 
beginning (onset) and ending (offset) of an epidemic season, sporadic RSV cases were calculated. 
Since there were no RSV-positive samples detected during the summer months, the time of beginning 
was determined as that time when the first positive samples were detected in at least three 
consecutive weeks. Conversely, the time of ending was defined as the time when the last samples in a 
cascade of positive samples were detected. The duration was defined as the number of weeks 
between the determined onset and offset weeks, and the epidemic peak was defined as the week 
after onset with the highest number of positive test results. The cutoff for determination of early and 
late seasons was set at week 49. Differences between weak and strong seasons were statistically 





PCR for molecular analysis of the G-protein gene.  
A representative number of group A RSV-positive samples (at least 20%) were selected for 
amplification of the second hypervariable region of the G-protein gene by either external or nested 
PCR. The first amplification was performed with 5 μl cDNA in a 50-μl reaction mixture by using 250 nM 
of each of the primer pairs RSVA-G513-F and RSVA-F131-R (Table 1), a 100 μM concentration of 
each deoxynucleoside triphosphate, 4 mM MgCl2, 0.5 U Platinum Taq DNA polymerase (Invitrogen), 
and PCR buffer (200 mM Tris-HCl [pH 8.4], 500 mM KCl). Amplification was carried out at 94°C for 5 
min, followed by 40 cycles of PCR, with 1 cycle consisting of 30 s at 94°C, 30 s at 58°C, and 1 min at 
72°C, and a final extension step of 10 min at 72°C. The amplified products of 583 bp were analyzed by 
electrophoresis on a 1.5% agarose gel. In the case of negative results, 5 μl of the external PCR 
mixture was used for nested PCR, which was performed in a 50-μl reaction mixture with 250 nM of 
RSVA-G606-F and RSV-F22-R (Table 1). The cycling protocol was the same as for the external PCR, 
except for the annealing temperature, which was 53°C. The nested amplicons of 391 bp were 
visualized by agarose gel electrophoresis as well. 
 
 
DNA sequencing.  
The PCR products were purified either directly with QIAquick PCR purification kit (Qiagen, Hilden, 
Germany) or from agarose gels with JETquick spin column technique (Genomed, Lo¨hne, Germany) 
according to the manufacturer’s instructions. Purified PCR products were cycle sequenced in the 
forward direction and the reverse direction with primer pair RSVAG513-F and RSVA-F131-R or primer 
pair RSVA-G606-F and RSV-F22-R (Table 1), respectively, in a 3130xl genetic analyzer (Applied 
Biosystems) by using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems). 
 
 
Phylogenetic analysis.  
A multiple-sequence alignment was compiled from the second variable region of the G gene (270 bp) 
of 221 sequences using ClustalW in the Bioedit version 7.0.9 (17). For determination of RSV group A 
genotypes, phylogenetic analyses were performed using the PHYLIP version 3.64 package (11). 
Sequence distances were calculated from alignments using F84, and clustering was done by the 
neighbor-joining algorithm of the PHYLIP program package. Unique representative sequences of each 
of the eight RSV group A genotypes were included in the phylogenetic analysis. GenBank accession 
numbers and the year and country of isolation of these sequences are given in Table 2. Phylogenetic 
relationships among German viruses were reviewed, and closely related strains were based on 
nucleotide similarity values of ≥96.6% abridged to one consensus sequence, which is now 
represented as a subtype in the tree. Evaluation of the robustness of the tree was performed by 
bootstrap analysis carried out with 1,000 replicates. The tree was plotted using TREEVIEW (33) and 
was manually edited in Corel Draw 12 program.  
 
Comparisons between nucleotide or amino acid sequences were calculated using the DNADist or 
Protdist tool, respectively, of the Bioedit software, and the divergence values determined were 
described in terms of mean and standard deviation. To estimate the numbers of potentially O-
glycosylated serine and threonine residues, NetOglyc software (version 3.1) (18) was used. 
Synonymous and nonsynonymous mutations were analyzed by the method of Nei and Gojobori (31). 
The program SNAP (Synonymous/Nonsynonymous Analysis Program) provided by the human 
immunodeficiency virus (HIV) sequence database website 
(http://www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html) was used for analysis of synonymous 
mutations versus nonsynonymous mutations. 
 
 
Nucleotide sequence accession numbers.  
The GenBank accession numbers of the nucleotide sequences obtained in the present study are 
FJ391237 to FJ391295, FJ391297 to FJ391327, and FJ391329 to FJ391459. Details concerning their 












Frequencies and distribution of RSV throughout consecutive seasons.  
Over 6,100 respiratory samples were tested for RSV from October 1998 to September 2007, and 23% 
(1,426) of the samples were found to be positive. To determine the prevalence of RSV infections in 
certain age groups, the percentage of RSV-positive samples was calculated out of all specimens 
tested per age group. As expected, the majority of positive individuals were infants younger than 3 
months (51%) and those aged between 3 to 6 months (47%). The prevalence of RSV decreased with 
increasing age, as observed for infants aged between 7 and 12 months (34%) and between 1 to 3 
years (23%). Patients older than 3 years were characterized by a positive rate of 7%. Moreover, 28% 
positive samples were detected in individuals of unknown age. Since the prevalence was highest in 
children between 0 and 3 years old, it is assumed that the majority of patients of unknown age were 
younger than 3 years old. 
 
RSV infections occurred in all seasons from late autumn to spring, and RSV peak activity varied within 
the seasons (Fig. 1). There were three out of eight seasons (2000 to 2001, 2002 to 2003, and 2006 to 
2007) with a very intensive circulation of RSV in Germany (estimated using chi-square test, P < 
0.0001). The onset, offset, peak, and seasonal pattern of RSV epidemics are documented in Table 3. 
A regular 2-year cyclic pattern was observed for two consecutive late and early seasons. An exception 
was the period between 2003 and 2005 where the pattern was changing from one season to the other. 
There was no correlation between onset and severity during the RSV epidemic season. 
 
 
Distribution of RSV group A in epidemic seasons.  
All 1,426 RSV-positive samples were first detected by a generic realtime reverse transcription-PCR, 
and subsequently, the majority (Table 4) was differentiated by specific real-time reverse transcription-
PCRs into RSV group A and B viruses. Table 4 shows the distribution of RSV group A viruses in nine 
epidemic seasons throughout the study period, and RSV group A viruses predominated in all epidemic 
seasons except for the season from 1998 to 1999 and that from 2002 to 2003. Indeed, there is no 
correlation between the distribution of RSV group A and the appearance of an early or late epidemic 
season. A representative number of more than 20% of group A viruses were randomly selected for 
sequencing and phylogenetic analyses irrespective of the severity of the epidemic season. 
 
 
Phylogenetic analysis of RSV group A sequences.  
A total of 221 group A RSV samples were sequenced and analyzed in a neighbor-joining tree. 
Analysis revealed that all RSV group A viruses belonged to three genotypes: 74 (33%) viruses to 
genotype GA2, 138 (62%) to genotype GA5, and 12 (5%) to GA7. Groups of identical sequences were 
identified for each genotype. Phylogenetic relationships among strains were, therefore, reviewed, and 
closely related strains, based on nucleotide similarity values of ≥96.6%, were further divided into 
groups that we arbitrarily designated subtypes (according to Peret et al. [39]). Genotypes GA2 and 
GA5 showed a high variability with 20 and 28 subtypes, respectively. GA7 includes only two subtypes 
(Fig. 2). 
 
Seasonal circulation pattern of RSV group A genotypes and subtypes.  
Phylogenetic analyses revealed that three out of eight different genotypes circulated in Germany 
during the last seasons: GA2, GA5, and GA7. All seasons were characterized by the appearance of 
genotypes GA2 and GA5. GA7 was present only during the seasons from 1999 to 2000 and 2002 to 
2003. Indeed, the extent of each genotype differed from one season to the other, but GA5 was the 
dominant genotype in the years from 1999 to 2007 (Fig. 3).  
 
The subtypes identified were analyzed for determination of the temporal circulation pattern of RSV 
throughout nine consecutive seasons (Table 5). There were several subtypes (A2.2, A2.4 to A2.7, 
A2.10, A5.2, A5.11, A5.12, A5.14, A5.15, A5.18, A5.19, A5.21, and A7.1) that showed identical 
sequences only within one season. In contrast, other subtypes contained identical sequences in either 
two (A2.1, A2.3, A2.8, A2.9, A2.12, A2.14, A2.15, A2.17, and A5.3 to A5.5), three (A5.10 and A5.25), 
or four (A5.13) consecutive seasons. Sequences of subtypes A5.7 and A5.8 were found in seven or 
eight consecutive seasons. There were also some subtypes representing single sequences not 
clustering with other sequences (A2.18 toA2.20, A5.27, and A7.2). Two subtypes are characterized by 
a biennial (A2.13) or triennial (A5.16) rhythm. In total, there were two genotypes, GA2 and GA5, 
  
circulating over nine consecutive seasons. The appearance, disappearance, or rather recurrence of 
genotype-specific viruses was, however, a random event. 
 
 
Intragenotype divergence of German RSV group A sequences. 
The nucleotide sequence and the deduced amino acid sequence of the second variable region of all 
German viruses were compared within each genotype and the mean percentage of nucleotide and 
amino acid divergences are shown in Table 6. Nucleotide divergence ranged between 0.5% and 3.7%, 
whereas the most similar viruses belonged to genotype GA7. In contrast, the amino acid divergence 
ranged from 1.5% to 12.5%. All sequences revealed a higher degree of amino acid divergence 
compared to the degree of nucleotide divergence. 
 
 
Synonymous-to-nonsynonymous mutations.  
To study the evolutionary divergence of the RSV sequences, the number of synonymous (silent) and 
nonsynonymous (amino acid altering) nucleotide substitutions was estimated. On average, the 
synonymous mutation/nonsynonymous mutation (ds/dn) ratio for the three RSV group A genotypes 
were 1.18 for genotype GA2, 4.34 for genotype GA5, and 1.92 for genotype GA7. Ratios of >>one 
demonstrate a high abundance of synonymous mutations. This implicates a neutral selection pressure 
on the variable region for genotype GA5 and GA7. A positive selection pressure can be suggested for 
genotype GA2, for which more nonsynonymous mutations have been observed. 
 
 
Amino acid analysis.  
A consensus sequence was generated including all nucleotide sequences of a subtype and was 
translated into one amino acid sequence. Predicted amino acid sequences of all subtypes were then 
compared to prototype strain A2 (Fig. 4 and Table 7). Nearly all partial G-protein gene sequences 
were predicted to encode G proteins of 298 amino acids in length. Only three GA2 subtypes (A2.12, 
A2.17, and A2.18) and one of GA5 (A5.5) encoded a G protein with 297 amino acids. The difference in 
the length of the deduced amino acid sequences of subtypes A2.17 and A2.18 as well as of A5.5 
resulted from a mutation at the second nucleotide position and a mutation at the first nucleotide 
position in the first stop codon in the carboxyl terminus of the G-protein gene. Amino acid substitutions 
that were specific for each of the three analyzed genotypes were identified. Each genotype could be 
distinguished from the others based on particular amino acid substitutions at different positions along 
the deduced amino acid sequence. For instance, genotype GA2 could be distinguished by Thr269and 
Ser289, and genotype GA5 could be distinguished by Ala225, Asn250, Ser251, Thr274, and Ile279. 
Amino acid substitutions Ile295 and Asp297 were also specific for genotype GA5 with the exception of 
subtypes A5.14, A5.16, and A5.20. Genotype GA7 could be differentiated by certain amino acid 
substitutions as well. These were Arg240, Gly244, and Thr250 (Fig. 4). 
 
Glycosylation sites.  
The G protein is heavily glycosylated with both N-linked and O-linked sugars (60). We identified four 
putative N-glycosylation sites (NXT, where X is not Pro) among group A subtypes, whereas the 
positions of the first and fourth sites were nearly conserved among all subtypes (Fig. 4). Only subtypes 
A2.12 and A5.26 as well as subtypes A5.3 and A5.28 lacked the first glycosylation site or rather the 
fourth glycosylation site. The second site was genotype specific and was present only among GA5 
subtypes. In contrast, the third site was identified among genotype GA2 and GA7 viruses. Most of the 
carbohydrates of the G protein are O glycosylated. Thereby serine and threonine residues are 
potential attachment sites for O-linked sugars, and the G protein has an unusually high content of both 
(9). The analysis of 89 amino acids by the program NetOglyc predicted 22 to 34 serine and threonine 
residues to be potentially O glycosylated with score predicators (G scores) of 0.5 and 0.8. 
Interestingly, there were two O-glycosylation sites that were either unique to genotype GA2 and GA7 
(T241) or GA5 (T274). In addition to serine and threonine residues, one to three repeats of the motif 
KPXnTTKXn (Fig. 4) were present among the subtypes and may be associated with extensive O 










RSV is the most common viral pathogen causing lower respiratory tract infections among infants and 
young children (48). Infection rates for RSV of 68.8/100 children during the first year of life and 
82.6/100 during the second year have been observed (16). The incidence of RSV-associated 
bronchiolitis and pneumonia was highest in 2- to 3-month-old infants, whereas with increasing age, the 
incidence decreased (36, 47). In this study, RSV was detected in over 1,400 respiratory samples 
over a period of nine consecutive seasons. Most infected individuals were babies 0 to 3 months old 
accounting for 51% of all samples analyzed and babies between 3 and 6 months accounting for 47% 
of all samples analyzed in these age groups. With increasing age, the RSV prevalence decreased to 
levels of 23% in children between 1 and 3 years old. Long-term studies from Germany analyzing the 
impact of RSV in hospitalized children confirm our findings (3, 57). These data revealed that 22.8% to 
42.8% were positive for RSV in the age group between 0 and ≤ 12 months (54, 56). In children older 
than 1 year, the prevalence of RSV was decreasing (54). The frequency of RSV particularly in small 
children might be caused by their immune status. Although high levels of maternal antibodies are 
protective against the disease, the magnitude of such immune response in the early years is low. 
Thus, the majority of children become infected during the first months of life. Both serum and secretory 
antibodies are produced in response to infection, even by very young infants; in this group, however, 
titers achieved are usually low (7, 26, 55). Significant boosting, particularly for the immunoglobulin G 
and immunoglobulin A responses, will develop soonest when children are reinfected for the second or 
third time (43). 
 
RSV was isolated from autumn to spring in all nine seasons investigated herein. Thus, RSV is 
circulating mainly in the winter months as determined by other studies of the temperate zone (23). 
Monitoring of RSV activity in Germany revealed a 2-year cyclic pattern for two consecutive late and 
early seasons. An exception was the period between 2003 and 2005 when the seasonal pattern was 
changing from one season to the other. Other European countries, such as Switzerland, Sweden, and 
Finland, observed a yearly varying pattern of early and late seasons, whereas early seasons are 
associated with high incidences and vice versa (10, 41, 53). Previous reports from Germany including 
regions around Kiel, Stuttgart, and Freiburg also described a biennial rhythm of severe early and weak 
late seasons (3, 50, 58). An explanation for the absence of the biennial pattern in our study might be 
due to missed cases during summer months which would influence the onset of a season. Apart from 
that, we observed no frequency in severe or weak RSV seasons as described previously. So far, this 
finding cannot be explained since, first, in every season a huge number of cases were both detected 
and examined and, second, the hospitals and physicians included in the study remained nearly 
unchanged during the nine seasons.  
 
Consistent shifts in RSV group dominance have been reported worldwide in which RSV group A 
viruses are more frequently detected. In Germany, RSV group A was dominant in seven out of nine 
epidemic seasons predominating over a period of three (1999 to 2000 to 2001 to 2002) and four (2003 
to 2004 to 2006 to 2007) seasons. During the same periods, mainly RSV group A dominated in 
several other countries (Table 8). A regular three-year cyclic pattern of group dominance was 
observed in Belgium and Argentina where RSV group A viruses predominated for two consecutive 
seasons (52, 63). A study in India reported on RSV group A dominance for three consecutive epidemic 
seasons (37). RSV group B predominated for a single season in the countries investigated and at the 
same or similar time as observed in Germany. Thus, it can be concluded that RSV group A 
predominated within similar seasons, implicating that most RSV infections were caused by RSV group 
A worldwide at the same time.  
 
RSV group A is classified into several genotypes (38, 39, 51). Three out of eight genotypes circulated 
in Germany between 1998 and 2007, and more than one genotype was detected within each season. 
Most of the German viruses belonged to the genotypes GA2 and GA5 demonstrating a dominance of 
GA5 in two and then four consecutive epidemic seasons. The finding of GA2 and GA5 as the most 
common genotypes of RSV group A is in agreement with the results of long-term studies from Europe 
and other geographic areas. Between 1964 and 1996, genotypes GA1, GA3, and GA4 circulated 
sporadically in addition to the genotypes GA2 and GA5 in Sweden, Belgium, Uruguay, Argentina, and 
the United States (12, 14, 39, 40, 62). In these and other countries, mainly the genotypes GA2 and 
GA5 and in a few cases genotype GA7 have been circulating since 1998 (12, 32, 37, 44). The 
continuous and predominant circulation of genotypes GA2 and GA5 demonstrate that these genotypes 
are stable and have become epidemic in many countries.  
 
  
Viruses isolated in Germany comprise sets of similar sequences within each of the identified 
genotypes. Some of them reemerged in subsequent seasons, and viruses of subtypes A5.7 and A5.8 
were circulating over long periods of six and eight seasons, respectively. It can be surmised that 
viruses circulating for years caused yearly new infections. Otherwise, there are RSV group A viruses 
appearing only once during the study period in Germany. One-third of those viruses emerged during 
the seasons 2000 to 2001, 2002 to 2003, as well as 2006 to 2007 and might be responsible for severe 
outbreaks. Presumably, strains came from outside Germany and were transmitted more efficiently due 
to a lack of immunity in the German population. Indeed, viruses isolated in Germany are closely 
related to viruses from distinct places (e.g., A2.8, A2.9, and LLC235-267 from Singapore; A2.13 and 
Ab4026B01 from South Africa; A5.27 and NG/009/02 from Japan; A5.16 and Sal/173/99 from Brazil; 
and A7.2 and CN1973 from Canada), suggesting that RSV group A strains are distributed worldwide 
as described previously (5, 15).  
 
A reason for the long-lasting circulation of genotypes GA2 and GA5 in Germany might be due to 
mutations in their amino acid sequences. The nucleotide divergence determined for genotype GA2 
was 3.7%, and for GA5, it was 3% (both values representing low levels). Since amino acid divergence 
of the genotypes GA2 (12.5%) and GA5 (7.5%) was greater than the nucleotide divergence, mutations 
in nucleotides resulted in amino acid changes. For genotype GA2, more nonsynonymous mutations 
were observed, indicating a positive selection pressure for those viruses, which may be reasonable for 
the longlasting circulation. Contrary to this, selection pressure for GA5 is neutral due to the existence 
of more synonymous mutations. The significance of this observation is not known so far. In Stockholm, 
Sweden, the genotype GA5 also has dominated over a couple of epidemic seasons, and it is 
speculated that a variation in the A-terminal part of the protein may result in the prolonged dominance 
of this genotype, whereas in the C-terminal part, little divergence was detected (40). This might be 
also a reason for the circulation pattern of the German GA5 viruses. At present, there is not sufficient 
information about the A-terminal part of the protein to support the data from Stockholm, Sweden, or 
rather the hypothesis.  
 
The amino acid sequences of German subtypes were predicted to encode G proteins of 297 or 298 
amino acids in length. This is in agreement with data from Uruguay and Argentina where both these 
changes in protein length were observed and were correlated with genotypes. Viruses with a G-protein 
length of 297 amino acids grouped into GA1 and GA2. Viruses representing genotypes GA3 and GA5 
had a G-protein length of 298 amino acids (12). We found that subtypes A2.12, A2.17, and A2.18 of 
genotype GA2 and subtype A5.5 of genotype GA5 code for the 297-amino-acid variant. All other 
subtypes possessing 298-amino-acid G proteins were found to belong to genotypes GA2, GA5, and 
GA7. German group A RSV viruses differed not only with regard to the length of amino acids but also 
revealed genotype-specific amino acid substitutions as described previously (14, 39, 40, 51, 52). 
Interestingly, most substitutions found worldwide were different between geographical locations, 
suggesting that RSV strains develop independently. Amino acid substitutions at positions 269, 274, 
and 295 observed in German subtypes were also found in Argentinean and South African viruses and 
strains from Rochester, New York (14, 39, 51) as a consequence of global circulation of strains.  
 
N and O glycosylation of the G protein is suggested to help the virus evade the host immune response 
(6). Variation in the number and distribution patterns of glycosylation sites can influence the 
expression of certain epitopes, and therefore, recognition of RSV by carbohydrate-specific antibodies 
can be inhibited (27, 34, 35). The predicted O-glycosylation sites in the second hypervariable region of 
the G-protein gene analyzed in this study included 22 to 34 residues. For the same region, 8 to 10 
potential O-linked glycosylation sites were identified in group A RSV strains from India (37). On the 
basis of RSV strains from Belgium, serine and threonine residues were predicted to be O-glycosylated 
with a high potential at the positive selected sites at positions 290 and 225 (62). German viruses did 
not possess such potential glycosylation sites, and a serine or threonine residue was not located at 
these sites. However, potential N- and O-glycosylation motifs among German viruses were observed, 
which have been described previously (37, 42). Two to four putative N-glycosylation sites have been 
estimated for the German viruses of genotype GA2, GA5, and GA7. The number of potential Olinked 
acceptor sites varies considerably among viruses within a genotype. Consequently, glycosylation of 
the Gprotein gene is highly variable in RSV strains. The modulation of the number and location of the 
glycosylation sites may cause the long-lasting circulation of certain genotypes, as the viruses 
circumvent neutralization by preexisting antibodies. In general, further analyses are necessary to 
understand the functional importance of glycosylation sites. This information might help to predict 
possible changes in virulence and immune responses to RSV strains in future vaccination programs.  
 
  
In summary, RSV was mainly detected among small children from autumn to spring during nine 
epidemic seasons in Germany. Molecular characterization of RSV revealed the predominance of RSV 
group A viruses for three and then four consecutive seasons. Most German viruses belonged to the 
genotypes GA2 and GA5, which are the predominant genotypes circulating worldwide. Positive 
selection pressure or modulation of glycosylation sites among genotypes are most likely responsible 
for the prolonged circulation of these genotypes in Germany. At present, detailed data on the 
circulation of RSV group A genotypes over a couple of seasons are available for only some countries. 
This study thus contributes to a better knowledge on the molecular epidemiology of RSV group A in 
Europe and provides data for a comparative analysis with group A strains circulating in other regions 
of the world. Comprehensive information on the circulation profile of RSV is important for the selection 
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Tables and Figures 
 




a Nucleotide positions are given according to the gene positions in RSV strain A2 (GenBank accession 
number U50362). All oligonucleotides were purchased from TibMolbiol GmbH (Berlin, Germany). 
Abbreviations: F, 6_-carboxyfluorescein (FAM); BHQ1, black hole quencher 1; X, 6’-












































a Number of samples differentiated by specific real-time reverse transcription- PCRs into RSV group A 



































a Subtypes were defined as _96.6% nucleotide similarity and denoted with a three-character code. 
b n is the number of identical sequences (subtypes A2.12, A5.5 and A5.7 showed two distinct groups 
of identical sequences). 
c n is the number of isolates found in that season. 
 
 
Table 6 Nucleotide and amino acid divergence of the carboxyterminal variable region of the G protein 










Table 7 Amino acid positions of RSV group A subtypes when two amino acids were presented in 













a Data from reference 32. 
b Data from reference 63. 
c Data from reference 52. 
d Data from reference 44. 
e Data from reference 45. 


















Figure 1 Number of total samples investigated and number of RSV-positive samples from 1999 to 
2007. Results are shown for each month of eight epidemic seasons (from left to right, October [O], 
November [N], December [D], January [J], February [F], March [M], April [A], May [M], June [J], July 














































Figure 2 Phylogenetic tree of the second variable region of RSV group A genotypes and subtypes. 
The prototype strain USA/Long/56 was used as the outgroup in the analysis. Reference sequences 
describing the eight different genotypes were retrieved from GenBank and included in the tree. The 
tree was constructed using the neighbor-joining algorithm with 1,000 replicates through PHYLIP. 
Subtypes are shown in boldface. The genotypes are indicated by the brackets to the right of the figure. 
Only bootstrap values greater than 70% are displayed at the branch nodes. The scale bar indicates 









Figure 3 Distribution of RSV group A genotypes over eight consecutive seasons. The number of 












































Figure 4 Deduced amino acid alignment of the second variable region of the G-protein gene from RSV 
group A subtypes. Consensus sequences are generated from each subtype, and the alignment is 
shown relative to the sequence of prototype strain A2 (GenBank accession number M11486). The 
amino acids shown correspond to strain A2 G-protein positions 212 to 298. Identical residues are 
indicated by dots, and stop codons by asterisks. The presence of an X at an amino acid position 
indicates that there was not a consensus for the subtype at that position and both amino acids were 
presented in equivalent proportion among the studied strains. The corresponding amino acids and 
positions are further described in Table 7. Potential N-glycosylation sites (NXT, where X is not proline) 
are underlined. Potential sites for extensive O-glycosylation KPXnTTKXn motifs (where X is any amino 
acid) are indicated by gray shading. Half of the sequences of subtype A5.28 contain either a potential 
O-glycosylation site (double underline) and/or an N-glycosylation site (thick underline). 
 
 
 
 
  
